1Ribatti D,Vacca A,Nico B,et al.Angiogenesis spectrum in the stroma of B-cell non-Hodgkin’s lymphoma: an immunohistochemical and ultrastructural study[].European Journal of Haematology.1996
2Aguayo A,O’Brien S,Keating M,et al.Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia[].Blood.2000
3Salven P,Teerenhovi L,Joensuu H.A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin’s lymphoma[].Blood.1999
4Dias S,Hattori K,Zhu Z,et al.Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration[].The Journal of Clinical Investigation.2000
5Mangi MH.Angiogenesis and angiogenic mediators in haematological malignancies[].British Journal of Haematology.2000
6Peichev M,Naiyer AJ,Pereira D,et al.Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors[].Blood.2000
7Lee SH,Schloss DJ,Swain JL.Maintenance of vascular integrity in the embryo requires signaling through the fibroblast growth factor receptor[].Journal of Biological Chemistry.2000
8Chen HJ,Treweeke TA,West DC,et al.In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells[].Blood.2000
9Carmeliet P.Mechanism of angiogenesis and arteriogenesis[].Nature Medicine.2000
10Aguayo A,Estey E,Kantarjian H,et al.Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia[].Blood.1999
1Moehler TM, Ho AD, Goldschmidt H, et al. Angiogenesis in hematologic malignancies. Crit Rev Oncol/Hematol, 2003; 45:227-244
2Bellon G, Martiny L, Robinet A. Matrix metalloproteinases and matrikines in angiogenesis. Crit Rev Oncol/Hematol, 2004 ;49:203-220
3Bairey O, Boycov O, Kaganovsky E, et al. All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells. Leuk Res, 2004; 28:243-248
4Hattori K, Dias S, Heissig B, et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med, 2001 ;193:1005-1014
5Lin LI, Lin DT, Chang CJ, et al. Marrow matrix metalloproteinases (MMP) and tissue inhibitors of MMP in acute leukemia; potential role of MMP-9 as a surrogate marker to monitor leukemic status in patients with acute myelogenous leukemia. Br J Hematol,2002; 117: 835-841
6Verstovsek S, Kantarjian H, Manshouri T, et al. Prognostic significance of celluar vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia. Blood, 2002; 99: 2265-2267
7Kay NE, Bone ND, Tschumper RC, et al. B-CLL cells are capable of synthesis and secretion of both pro-and anti-angiogenic molecules. Leukemia, 2002; 16:911-919
8Gora-Tybor J, Blonski JZ, Robak T, et al. Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia. Mediators Inflamm,2003; 12: 167-171
9El-Obeid A, Sunnuqrut N, Hussain A, et al. Immature B cell malignancies synthesize VEGF, VEGFR-1 (Flt-1) and VEGFR-2 (KDR). Leuk Res, 2004; 28: 133-137
10Tille JC, Wang X, Lipson KE, et al. Vascular endothelial growth factor (VEGF) receptor-2 signaling mediates VEGF-CδNδC-and VEGF-A-induced angiogenesis in vitro. Exp Cell Res, 2003; 285:286-298
